Research Solutions (RSSS) Q2 2026 earnings review
Profitability Surges, But Top-Line Growth Hits a Wall
Research Solutions delivered a paradox in Q2: financial maturity is accelerating while growth is stalling. The strategic pivot to high-margin Platforms drove a 36% surge in Adjusted EBITDA and flipped the company to GAAP profitability. However, the legacy Transaction business (-10%) and a sudden contraction in B2C ARR dragged total revenue into negative territory (-1%). While the B2B sales engine is executing well (record organic Q2 deployments), the stalling growth engine raises questions about the company's valuation multiple.
🐂 Bull Case
The mix shift is working perfectly for the bottom line. With Platform revenue now 44% of the total (up from 39%), gross margin expanded 350 basis points to 52.4%. This drove Net Income to $0.5M vs. a $2.0M loss last year.
B2B remains the bright spot. The company secured 47 net new deployments—the best organic Q2 performance in history. B2B ARR is up 20.3% YoY to $15.3M.
🐻 Bear Case
The B2C segment (Scite) has stalled dramatically. Incremental B2C ARR was negative (-$94k) this quarter, compared to +$940k in the prior year. The growth narrative relies heavily on this segment, and it is currently shrinking sequentially.
Transaction revenue fell 10% YoY, accelerating from the 4-8% declines seen in prior quarters. This segment still makes up 56% of revenue, making it difficult for the platform business to drive overall top-line growth.
⚖️ Verdict: ⚪
Neutral. The profitability turnaround is excellent, proving the business model works. However, the total revenue contraction and the sudden halt in B2C growth are significant red flags that prevent a bullish rating until top-line momentum returns.
Key Themes
B2C Segment Stalls Out
A major concern this quarter is the B2C segment (Scite). After driving the growth narrative in FY25, B2C ARR grew only 1.1% YoY and actually declined sequentially by ~$94k. Management pivots to calling B2C a 'lead funnel' for B2B, but the numbers show a growth engine that has seized up.
Mix Shift Driving Margin Breakout
The intentional shift from low-margin Transactions (24% GM) to high-margin Platforms (88% GM) is transforming the P&L. Total Gross Margin hit 52.4%, up from 43.5% just a year ago. This structural improvement allowed EBITDA to grow 36% despite revenue shrinking.
B2B Organic Strength
Amidst the noise, the core B2B Platform business is healthy. The company added 47 net new deployments (vs 61 last year, but noted as 'best organic' result). B2B ARR grew to $15.3M, up 20% YoY. Average Sales Price (ASP) is increasing (+6% YoY to $12,434), confirming successful up-market moves.
Transaction Revenue Erosion
The decline in the Transaction business is accelerating. Revenue dropped 10.2% YoY, worse than the 8.4% drop seen in the 6-month view. Management cited churn from a 'known customer' and volume declines from large accounts. This drag is currently overpowering Platform growth.
Cash Flow Inflection
The company has turned a corner on liquidity. Cash balance remained flat at ~$12.3M sequentially but doubled YoY. Operating cash flow remains positive, funding operations and allowing for reinvestment without dilution.
Other KPIs
Decelerating. Growth slowed to 14% YoY, down from 21% in Q1 and 23% in FY25Q3. The slowdown is entirely attributable to the B2C segment stagnation.
Accelerating. Up 36% YoY. Margin improved to 11% from 8% a year ago. The company is successfully converting gross margin expansion into operating leverage.
Stable/Growing. Up 14% YoY. While healthy, this growth rate must accelerate or maintain high levels to offset the larger nominal declines in the Transaction business.
Guidance
Stable. Management reiterated the goal to improve on the FY25 result of 34%. This implies a continued balance of EBITDA margin expansion and ARR growth, though the current ARR deceleration makes this target harder to hit via growth alone.
Key Questions
B2C Growth Collapse
B2C incremental ARR turned negative this quarter (-$93k). Is this purely seasonality/competition, or has the Scite product reached total addressable market saturation in the consumer vertical?
Transaction Business Floor
With Transaction revenue declining 10% and accelerating to the downside, at what quarterly revenue run-rate do you model this segment stabilizing?
Platform Growth Deceleration
Platform revenue growth slowed to 14% YoY this quarter compared to 21% in 25Q4. What is the catalyst to re-accelerate this to the 20%+ range needed to drive total company growth?